acFibroMASH index for the diagnosis of fibrotic MASH and prediction of liver-related events: An international multicenter study.
Feng G. et al, (2024), Clin Gastroenterol Hepatol
Prospective cohort for early detection of liver cancer (Pearl): a study protocol.
Khanna K. et al, (2024), BMJ Open, 14
Editorial for "MRI Extracellular Volume Fraction in Liver Fibrosis-A Comparison of Different Time Points and Blood Pool Measurements".
Pavlides M. and Mózes FE., (2024), J Magn Reson Imaging
Liver fibrosis phenotyping and severity scoring by quantitative image analysis of biopsy slides.
Watson A. et al, (2024), Liver Int, 44, 399 - 410
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical information.
McTeer M. et al, (2024), PLoS One, 19
Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis.
Qadri S. et al, (2024), JHEP Rep, 6
Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study.
Jackson C. et al, (2023), Lancet Respir Med, 11, 673 - 684
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Mózes FE. et al, (2023), Lancet Gastroenterol Hepatol, 8, 704 - 713
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease.
Sun D-Q. et al, (2023), Hepatobiliary Surg Nutr, 12, 386 - 403
Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls.
Zheng B. et al, (2023), Lancet Reg Health Eur, 29
Detection and alterations of acetylcarnitine (AC) in human liver by 1 H MRS at 3T after supplementation with l-carnitine.
Savic D. et al, (2023), Magn Reson Med, 89, 1314 - 1322
Machine learning algorithm improves detection of NASH (NAS-based) and at-risk NASH, a development and validation study.
Lee J. et al, (2023), Hepatology
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study.
Vali Y. et al, (2023), Lancet Gastroenterol Hepatol
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Pennisi G. et al, (2023), Hepatology
Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study.
McAuley HJC. et al, (2023), EClinicalMedicine, 57
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination.
Liew F. et al, (2023), EBioMedicine, 87